Fourteen mutant strains of Escherichia coli were examined, each of which requires tryptophan for growth but is unaltered in any of the genes of the tryptophan biosynthetic operon. The genetic lesions responsible for tryptophan auxotrophy in these strains map between str and malA. Extracts of these strains have little or no ability to charge transfer ribonucleic acid (tRNA) with tryptophan. We found that several of the mutants produce tryptophanyl-tRNA synthetases which are more heat-labile than the enzyme of the parental wild-type strain. Of these heat-labile synthetases, at least one is protected against thermal inactivation by tryptophan, magnesium, and adenosine triphosphate. Two other labile synthetases which are not noticeably protected against heat inactivation by substrate have decreased affinity for tryptophan. On low levels of supplied tryptophan, these mutants exhibit markedly decreased growth rates but do not contain derepressed levels of the tryptophan biosynthetic enzymes. This suggests that the charging of tryptophan-specific tRNA is not involved in repression, a conclusion which is further substantiated by our finding that 5-methyltryptophan, a compound which represses the tryptophan operon, is not attached to tRNA by the tryptophanyl-tRNA synthetase of E. coli.
Mutants have been isolated which have alterations affecting the aminoacyl transfer ribonucleic acid (tRNA) synthetases specific for alanine, arginine, glycine, histidine, phenylalanine, and valine (16) . Since the reactions catalyzed by these enzymes are essential for cell growth, and the end products of these reactions cannot easily be supplied exogenously, the isolation of such mutants is necessarily indirect. Mutants with temperature-sensitive valyl-, phenylalanyl-, and alanyl-tRNA synthetases have been identified among Escherichia coli strains selected for inability to grow at elevated temperatures (16, 27) . In 1967). Histidyl-tRNA synthetase mutants have been detected on another basis. The histidyltRNA synthetase of $almonella typhimurium plays an indirect role in repression of the histidine operon, and histidyl-tRNA synthetase mutants are readily found among strains derepressed for that operon (18, 19) .
The notion that certain aminoacyl-tRNA species are essential for repression of the corresponding biosynthetic operon has strong experimental support (4, 18-20, 22, 27) . When the charging of histidine-or valine-specific tRNA is limited, the enzymes of the histidine or valine operon are produced at elevated rates. Freundlich (7) has shown in studies with the valine operon that it is the charged tRNA, rather than free valine, the valyl-adenylate, or the synthetasevalyl-adenylate complex, that is required for repression. On the other hand, charged tRNA does not appear to play a regulatory role in the formation of the enzymes of the biosynthetic pathways for the aromatic amino acids phenylalanine and tyrosine. Temperature-sensitive phenylalanyl-tRNA synthetase mutants are not derepressed at growth-limiting temperatures (16) , and tyrosine analogues which repress the DOOLlMlIlLE AND YANOFSKY synthesis of tyrosine biosynthetic enzymes are not attached to tRNA (17) .
in the work reported here, we describe the isolation and characterization of tryptophanyltRNA synthetase mutants which are tryptophan auxotrophs. We show that these mutations affecting this aminoacyl-tRNA synthetase probably do not have direct regulatory consequences. Further, we show that a tryptophan analogue, 5-methyltryptophan, which represses the formation of the enzymes of the tryptophan operon, cannot be attached to tRNA by the tryptophanyltRNA synthetase of E. coli.
MATERIALS AND METHODS
Bacterial strains. The isolation of the tryptophanyltRNA synthetase (trpS) mutants studied is described in the Results. Tryptophan auxotrophs, trpA33, trpA9952, trpA9761, and trpB9700, were isolated in this laboratory from strains W31 10 or Ymel by penicillin selection. The deletion strain trpA-E1del was isolated as a phage Ti-resistant tryptophan auxotroph. Strain trpR2 carries a 5-methyltryptophan resistance marker, trpR (2) , in a W31 10 background.
Strain trpR18 (allelic with trpR2) and trpE19 PBR (feedback-resistant anthranilate synthetase) were isolated in this study as 5-methyltryptophan-resistant mutants of W3110. The tryptophanase-less, anthranilate synthetase mutant TPase--trpE3 was obtained from R.D. DeMoss.
Transductions and transduction mapping. Plkc lysates were prepared by the confluent lysis technique (24) and were used for transduction and mapping, as described previously (29) .
Growth media. Cells were grown with shaking at 37 C, in L broth (11), 0.8% Nutrient Broth (Difco), or in minimal medium (26) supplemented with 0.2% glucose, 0.05% acid-hydrolyzed casein (ACH) where noted, and varying levels of L-tryptophan.
Preparation of crude extracts. Cells were harvested by centrifugation, washed once with one-half volume (based on the original sample) of cold saline (0.85% NaCl), resuspended in buffer, and disrupted with a Branson Sonifier. Cell debris was removed by centrifugation at 18,000 X g for 15 to 20 min. The sonictreatment buffer was usually 0.1 M tris(hydroxymethyl)aminomethane (Tris)chloride (pH 7.8) when tryptophan synthetase A or B proteins were to be measured, and 0.1 M potassium phosphate buffer (pH 7.0) with 10-3 M 2-mercaptoethanol when tryptophanyl-tRNA synthetase was to be assayed. Either buffer was employed when all three enzymes were to be measured. Protein was determined by the procedure of Lowry et al. (12) . Specific activities are expressed as units of enzyme activity per milligram of protein (14, 23) .
Enzyme assays. Anthranilic acid synthetase, phosphoribosyl anthranilate transferase, indoleglycerol phosphate synthetase, and the A and B subunits of tryptophan synthetase were assayed by methods previously described (10, 23, 28) .
Tryptophanyl-tRNA synthetase was assayed in the charging reaction modified after the procedure of Muench and Berg (14) . The standard reaction mixture contained, per 0. acetate-ethyl alcohol precipitation described by Muench and Berg was omitted when the '4C-Ltryptophan was purified by passage through Dowex-1 (13) . We have found, however, that even tryptophan so purified often gives high background values after a few weeks of storage at -15 C, and so have generally employed the preliminary potassium acetate-ethyl alcohol precipitation. Preparation of tRNA. tRNA was prepared from 500 g of packed cells of W3110 by the method of Zubay (30) as modified by Muench and Berg (personal communication). After phenol treatment and NaCl extraction as described by Zubay, the ethyl alcohol precipitate was dissolved in 250 ml of 0.3 M sodium acetate (pH 7.0). Cold isopropanol (75 ml) was added, and the mixture was stirred for 10 min in the cold and then centrifuged for 10 min at 8,000 X g. The supernatant fluid was saved, and the pellet was redissolved and precipitated as above in one-third the original volumes of acetate and isopropanol. The two supernatant fractions were combined, and 250 ml of isopropanol was used in a third precipitation. The 8,000 X g pellet from this precipitation was dissolved in 225 ml of water, and 25 ml of 0.5 M Na2CO3 buffer (pH 10.2) was added. After 15 min of incubation at 37 C to remove amino acids still attached to tRNA, the solution was neutralized and the tRNA was precipitated by the addition of 25 ml of 5 M NaCl and 550 ml of cold ethyl alcohol. The precipitate was redissolved in 25 ml of water, and this solution was dialyzed against water overnight at 4 C. The final solution of tRNA was distributed among several tubes, which were stored frozen.
Preparation of 14C-5-methyl-L-tryptophan. Limiting amounts of 14C-L-serine (75 ,uc/,umole, uniformly labeled; New England Nuclear Corp.) and an excess of 5-methylindole (Nutritional Biochemicals Corp., Cleveland, Ohio) were used as substrates in the standard tryptophan synthetase reaction mixture with purified A and B subunits. After a suitable incubation period, cold serine was added to dilute any residual 14C-L-serine. The '4C-5-methyl-L-tryptophan obtained was partially purified by passage through BioGel P2. The purified material chromatographed identically to unlabeled 5-methyl-DL-tryptophan on the basic column of an amino acid analyzer. The specific activity of the 14C-5-methyl-L-tryptophan was the same as that of the serine from which it was prepared. Other, unlabeled analogues of tryptophan were obtained from various commercial sources.
RESULTS
Isolation of mutants. The tryptophanyl-tRNA synthetase (trpS) mutant strains described in Table 1 were found among tryptophan auxotrophs routinely isolated in this laboratory by penicillin selection of ultraviolet-irradiated bacteria. All grow poorly or not at all on minimal agar, or minimal agar supplemented with anthranilic acid (1 to 10 Ag/ml), but grow well on agar containing indole (10 ,ug/ml) More detailed genetic analyses with mutants trpS10330 and trpS10343 revealed that the trpS marker is about 15% cotransducible with either str or maltose-A (malA). Since str and malA are themselves only about 1% cotransducible, the trpS locus is concluded to lie between str and malA. The results of a typical experiment are presented in Table 2 .
Biochemical characterization of trpS mutants. Crude extracts of all the strains were prepared by sonic treatment in 0.1 M potassium phosphate buffer (pH 7.0) containing 10-3 M 2-mercaptoethanol. Extracts of one of the trpS mutants, trpS10330, were examined for the tryptophan biosynthetic enzymes. The presence of wild-type levels of anthranilate synthetase, phosphoribosylanthranilate transferase, indoleglycerol phosphate synthetase, and tryptophan synthetase A and B proteins was verified. TryptophanyltRNA synthetase levels were determined in the charging assay by using, as acceptor, tRNA prepared from wild-type W3110 cells. When mutant cells were sonic-treated in the above buffer, the majority of the extracts were incapable of charging transfer RNA with tryptophan at 37 C ( Like the genetic determinant responsible for auxotrophy in trpS mutants, the locus responsible for low levels of tryptophanyl-tRNA synthetase activity in trpS10330 is cotransducible with str.
In Table 3 , the tryptophanyl-tRNA synthetase and tryptophan synthetase A protein levels of wild-type W3110, trpR2 [mutant at the regulatory locus (2)], and trpEJ9FBR (a mutant of W3110 resistant to feedback inhibition by 5-methyltryptophan) are compared with those of the str-r tryptophan auxotrophs derived from these strains in crosses with str-r-trpS10330. We also found that, when an episome (F' 20) which covers the str-malA region is introduced into trpS-10343-malA-, the resulting mar heterogenotes are prototrophs and have regained normal levels of tryptophanyl-tRNA synthetase activity. Thus, we can conclude that the genetic alterations responsible for tryptophan auxotrophy in the trpS mutants also cause the lowered tryptophanyltRNA synthetase levels.
We suspected that the apparent absence of tryptophanyl-tRNA synthetase activity in vitro might not represent in vivo activity, since under certain conditions the trpS mutants are able to grow at only slightly reduced rates (see below). It is conceivable that mutant tryptophanyltRNA synthetases may be destroyed during sonic treatment or may, for other reasons, be inactivated in vitro. This is probably the case with the altered valyl-tRNA synthetase studied by Eidlic and Neidhardt (3). Yaniv (personal communication) found that certain mutant valyltRNA synthetases are unstable (in vitro and in vivo) in the absence of valine and magnesium.
To determine whether a similar instability was responsible for our failure to detect activity in extracts made by sonic treatment in buffer, (Table 4) . Maximal activity could be preserved only when all three components were present. Tubes 13 and 14 were controls which served to show that it was indeed charging of the tryptophan-specific tRNA that we were observing and not magnesium-and ATP-dependent incorporation of "C-L-tryptophan into other acid-insoluble material.
We subsequently found that the activity of sonic-treated trpS mutants trpS9897, trpS10110, trpS10330, and trpSJO343 was increased when sonicaily treated in buffer supplemented with tryptophan, magnesium, and ATP. The activity of sonic extracts of trpS9969 and trpSO0160 was not affected (Table 5 ). Sonic treatment in supplemented buffer was employed to prepare extracts for the examination of temperature sensitivity.
Temperature sensitivity of the altered synthetases. Although none of our mutants was selected on the basis of temperature sensitivity, strains trpS9969, trpSJ0110, trpS10330, and trpS10343 produced tryptophanyl-tRNA syn thetases that were relatively less active in vitro, at high temperatures, than was the wild-type enzyme (Fig. 1) . We examined the temperature sensitivity of the trpS9969 enzyme in somewhat more detail (Fig. 2) . The kinetics of tRNA charging by extracts of W3110 and trpS9969 were followed in the standard reaction mixture at 35 and 40 C. The tube at 40 C containing the trpS9969 extract was moved to a 27 C bath after 20 min at the higher temperature. The results suggest that the trpS9969 activity is as stable at 35 C as that of the wild-type enzyme; at 40 C, the mutant synthetase is irreversibly inactivated. This thermal instability is reflected in the temperature sensitivity of the tryptophan requirement of In tryptophan-rich media (L broth, or minimal medium or nutrient broth supplemented with 20 jig of L-tryptophan per ml), the doubling times of trpSIO110, trpS10330, and trpS10343 did not differ significantly from that of trpA9952. In tryptophan-poor media, however, the doubling time of trpS1O330 was considerably increased, whereas that of trpA9952 was unaffected ( Table 7) . The latter behavior is typical of strains mutant in the tryptophan operon; i.e., such strains grow exponentially at a rate unaffected by the exogenous tryptophan concentration but enter stationary phase at a turbidity which is roughly proportional to the level of tryptophan initially supplied (over a range of 0 to 5 or 10 Mg of Ltryptophan per ml; Table 8 ). Mutant trpS1O330, in contrast, grows slowly at low levels of tryptophan but continues to grow to a final cell density independent of the supplied tryptophan and comparable to the density of wild-type growing in minimal medium or of a trp operon mutant growing at nonlimiting levels of tryptophan (Table 8) .
If stationary rather than log-phase cultures are used as inocula in growth experiments, a further but probably related difference appears between the two types of tryptophan auxotroph (Fig. 3) .
Tryptophan synthetaseA CRM-mutant trpA9761 and trpS10330 were grown in minimal medium supplemented withlO,g (per ml) of L-tryptophan and 0.1% glucose until growth stopped. The cells were harvested, washed, and inoculated into fresh medium containing 0.2% glucose and various levels of tryptophan. Turbidity was followed as above. Mutant trpA9761 entered logarithmic phase rapidly, and growth was nearly independent of the level of exogenous tryptophan until the tryptophan was exhausted; trpS10330, on the other hand, exhibited a very long lag when in media with low levels of the amino acid.
Regulatory properties of trpS mutants. Regulatory effects of mutations in the trpR gene or in the tryptophan operon itself are routinely investigated by determining specific activities of tryptophan synthetase A or B protein in overnight (15 to 20 hr) cultures grown in minimal medium supplemented with 0.2% glucose, 0.05% ACH, and "repressing" (20 to 50 ,g/ml) or "derepressing" (O to 5 ,ug/ml) levels of L-tryptophan. Under "repression conditions," so defined, none of the trpS mutants produces levels of A protein significantly higher than that of wild type (Table 1) . Nor, under the same conditions, do the double mutants trpS10330-trpR2 and trpS10330-trp E19FBR have levels of A protein different from that of the trpS+ control strains (Table 3) . On the other hand, when various trpS mutants are grown overnight in media containing low initial levels of tryptophan (1 jAg/ml) and harvested long after growth has stopped, the specific activity of tryptophan synthetase A (or B) protein is indeed elevated to levels comparable to those obtained with mutants of the tryptophan operon ( Table 9 ).
The determination of specific activities of extracts of overnight (stationary) cultures is, of course, a very crude method of assessing the regulatory effects of trpS mutations. It is more pertinent to ask whether there is derepression of the tryptophan biosynthetic enzymes under conditions in which the growth of mutant cells is limited by their ability to charge tryptophanspecific tRNA. This question has been examined in three ways.
(i) In the experiment presented in Fig. 4 , cultures of W3110, trpA9952, and trpS10330 growing exponentially in minimal medium supplemented with L-tryptophan (20 ,ug/ml) and 0.2% glucose were harvested, washed with 0.85% NaCl, and inoculated, at time zero, into fresh medium containing L-tryptophan (2,ug/ml) and 0.2% glucose. Turbidity was followed, and, at various times, samples were harvested, treated sonically, and assayed for tryptophan synthetase A and B proteins. Exponential growth began immediately in all three cultures, but, whereas the doubling times of W3110 and trpA9952 were nearly identical (71 and 74 min, respectively), that of trpS10330 was nearly twice as great (135 min). Although the growth of trpS10330 was limited by this low level of tryptophan, the extent of derepression was no greater than that of wild type and, indeed, appeared initially to be less.
(ii) In a similar and equally pertinent experiment, logarithmically growing nutrient broth cultures of trpA9952 and ttpS10330 were harvested, sonically disrupted, and assayed for tryptophan synthetase B protein. The B protein specific activity was found to be 1.5 units/mg for the first and 1.7 units/mg for the second culture, although the doubling time of trpA9952 was 36 min and that of trpS10330 was 237 min at the time of harvesting.
(iii) In a third experiment (Fig. 5 ), turbidity and B protein specific activity of the A CRM+ mutant trpA33 (in a W3110 background) and of (Note that the specific activity scale is reduced for trpA9952.) the double mutant trpA33-trpSJO330 were followed as the supplied tryptophan (5 ,ug/ml) was exhausted from the medium. It is clear that, in the double mutant, the production of B protein stopped simultaneously with the cessation of growth, whereas, in the trpA33 control, B protein synthesis continued and a specific activity fourfold higher than that of the double mutant was attained by the end of the experiment. Therefore, when growth and, we assume, tryptophan-specific tRNA charging are limited in trpS mutants, the synthesis of the enzymes of the tryptophan operon is not derepressed.
A different kind of experiment also suggests that the charging of tryptophan-specific tRNA is not essential for repression. It is known that 5-methyltryptophan represses the synthesis of the tryptophan biosynthetic enzymes (2) . This is also shown in Table 10 and the reaction was initiated by the addition of samples of a W3110 extract. In one set of tubes, the amount of extract added was sufficient to charge only 20% of the available tRNA in 10 min ("limiting extract"). In the second set of tubes, extract was added in an amount twice that sufficient to charge all of the available tRNA in 10 min ("excess extract"). We can argue from the results ( Table 11 ) that, although 5-methyltryptophan in sufficient excess inhibits the charging of tRNA, it does not do so by being itself attached to tRNA. If tRNA were charged with 5-methyltryptophan, the rate of charging (relative to that with tryptophan) should be independent of the amount of extract employed, and an equal inhibition should have been observed with both enzyme levels. Our conclusion that 5-methyltryptophan does not charge tRNA is in agreement with earlier observations that the analogue does not catalyze pyrophosphate exchange with enzyme isolated from beef pancreas (21) orwith E. coli extracts (15) .
DIscussIoN
In this paper we report the isolation of a group of 14 tryptophan auxotrophs which differ phenotypically and genetically from mutants altered in any of the five genes of the tryptophan operon. In 11 trpS strains tested, the mutation responsible for auxotrophy was cotransducible with the streptomycin-resistance locus. A more precise genetic analysis with two of these strains revealed that the trpS locus lies between str and malA. Extracts of all 14 trpS strains tested had little or no detectable tryptophanyl-tRNA synthetase activity. In the six strains most closely examined, the enzyme activity that was detected was associated with a protein with (i) a temperature lability greater than that of wild type, (ii) a stabilization requirement for tryptophan, Mg+, and ATP more pronounced than that of the wild type, or (iii) a Km for tryptophan higher than that of the wild-type enzyme. We conclude that these six strains, and probably the remaining eight, carry mutations in the structural gene for tryptophanyl-tRNA synthetase and that this structural gene lies between str and malA on the genetic map of E. coli (25) . Yura (personal communication) and Matsushiro (personal communication) reached a similar conclusion.
The fact that the tryptophan aminoacyl-tRNA synthetase structural gene maps far from the specific amino acid biosynthetic operon conforms to the pattern emergingfor other aminoacyl-tRNA synthetases (1, 16) . The tryptophanyl-tRNA synthetase structural gene does map very close to two genes controlling steps earlier in aromatic amino acid biosynthesis, not specific to tryptophan (aroB and pabA; 9), thus correlating with the finding of Bock and Neidhardt (1) that the phenylalanyl-tRNA synthetase structural gene lies near to yet another gene governing an early step in the aromatic pathway (aroD). The meaning of this correlation is unclear.
Our trpS mutants, when suddenly deprived of tryptophan, grow poorly or not at all, behaving in this respect like "normal" tryptophan auxotrophs. At least one of our strains (trpS10330) is unlike "normal" tryptophan auxotrophs, however, in that it shows increased generation times and long lag periods when introduced into liquid media containing low levels of tryptophan. On high levels of this amino acid, the growth of mutant trpS10330 is "normal." The growth properties of our other trpS mutants, although less extensively examined, are similar. These properties are not inconsistent with the finding that at least some of our trpS mutants produce tryptophanyl-tRNA synthetases which have abnormally high Km values for tryptophan or are exceptionally labile in the absence of the amino acid. These growth properties further suggest that our trpS mutants do not form the tryptophan biosynthetic enzymes at levels sufficiently high to allow normal growth at low levels of supplied tryptophan. Thus, the reduced ability to charge tryptophan-specific tRNA does not in itself appear to lead to derepression. This notion is supported by the finding that, under conditions in which growth and, we assume, charging are limited, there is no derepression of the tryptophan biosynthetic enzymes of trpS10330. In addition, 5-methyltryptophan, which is known to repress, cannot be attached to tRNA by the E. coli enzyme. Our finding that cultures of trpS mutants grown at very low levels of supplied tryptophan, and harvested long after growth had stopped, showed elevated levels of the biosynthetic enzymes (Table 9) remains to be explained.
It should be mentioned here that we had earlier obtained, by a different technique, trpS mutants which have pronounced regulatory peculiarities. These strains were isolated as tryptophan auxotrophs from an ultraviolet-mutagenized population of cells diploid for the tryptophan operon [carrying the F' cys trp episome of Fredericq (6) ]. These strains are deficient in tryptophanyltRNA synthetase and produce very high levels (approximately 150 units/mg) of tryptophan synthetase A and B proteins, even under repression conditions. We currently believe these strains to have resulted from multiple mutational events and perhaps to be like some of the strains similarly obtained by Hiraga et al. (8) .
On the basis of the experiments reported here, we conclude that it is unlikely that tryptophancharged tRNA plays an important role in repression of the tryptophan operon. A possible role for the synthetase itself, for the synthetasetryptophanyl-adenosine monophosphate (AMP) complex, or for tryptophanyl-AMP, cannot as yet be ruled out. Finally, it should be pointed out that our studies were restricted to tryptophanyl-tRNA synthetase alterations that result in auxotrophy, and thus we cannot exclude the possibility that other types of synthetase alterations may result in derepression.
